Antibiotics Against Amyloid Angiopathy (BATMAN)

Leiden University Medical Center (LUMC)

Status and phase: Enrolling; Phase 2; Phase 1

Conditions: Cerebral Amyloid Angiopathy

Treatments: Drug: Placebo; Drug: Minocycline

Study type: Interventional

Funder types: Other

Identifiers

NCT05680389

2019-004786-41 (EudraCT Number)

P19.110

Details and patient eligibility

About

We will perform a randomized clinical trial with minocycline. Minocycline is an antibiotic of the tetracycline family and known to modulate inflammation, gelatinase activity and angiogenesis, which we know are central mechanisms in CAA-pathology. Our aim is to prove in a randomized clinical trial in a translational setting that minocycline treatment (duration 3 months) can decrease markers of neuroinflammation and the gelatinase pathway in the cerebrospinal fluid (CSF) of persons with D-CAA (n=30) and sporadic-CAA (n=30).

Enrollment: 60 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥18 years for D-CAA and age ≥55 years for sporadic-CAA
• Probable-CAA according to the Modified-Boston-Criteria or genetically proven D-CAA
• ≤ 2 ICH (occurrence of ICHs at least 1 year ago) and presence of ≥ 2 lobar microbleeds +/-cortical superficial siderosis
• Written informed consent

Exclusion criteria

• Previous allergic reactions to minocycline
• Modified Rankin Score ≥3
• Contraindications, such as:
• Contraindications for 7T MRI as determined by the 7Tesla safety committee. Examples of possible contra-indications are: claustrophobia, pacemakers and defibrillators, nerve stimulators, intracranial clips, intraorbital or intraocular metallic fragments, cochlear implants, ferromagnetic implants, hydrocephalus pump, intra-uterine device, permanent make-up, tattoos above the shoulders. In case of specific contra-indications for 7T a 3T will be made instead. - Specific contraindications for checkerboard fMRI: seizure within prior year, photosensitive epilepsy, noncorrectable visual impairment. - Contraindications for lumbar puncture: compression of the spinal cord, signs and symptoms of increased intracranial pressure, local infections of the skin at the puncture site, a coagulopathy or thrombocytopenia (<100). (Use of acetylsalicylic acid, NSAIDs, COX2 inhibitors or low-molecular-weight heparin are no contraindications for lumbar puncture.)
• Pregnancy/breast feeding
• Liver/renal failure
• Use of antibiotics <1 month
• SLE or other diseases known to generate inflammatory responses
• Previous/current/planned use of retinoids (since this is related to increasing risk of increased intracranial pressure)
• Current use of anaesthetics like methoxyflurane, agents inhibiting peristalsis, barbiturates, carbamazepine or fenytoïne

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

60 participants in 2 patient groups, including a placebo group

Minocycline

Experimental group

Description:

100 mg twice daily for 3 months

Treatment:

Drug: Minocycline

Placebo

Placebo Comparator group

Description:

twice daily for 3 months

Treatment:

Drug: Placebo